HORENSTEIN, ALBERTO
HORENSTEIN, ALBERTO
SCIENZE MEDICHE
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes.
2013-01-01 Horenstein AL;Chillemi A;Zaccarello G;Bruzzone S;Quarona V;Zito A;Serra S;Malavasi F
A murine, bispecific monoclonal antibody simultaneously recognizing β-Glucan and MP65 determinants in Candida species
2016-01-01 Zito, Andrea; Bromuro, Carla; Mandili, Giorgia; Chiani, Paola; Horenstein, Alberto L.; Malavasi, Fabio; Cauda, Roberto; Cassone, Antonio; Torosantucci, Antonella
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation
2015-01-01 Morandi, Fabio; Morandi, Barbara; Horenstein, Alberto L.; Chillemi, Antonella; Quarona, Valeria; Zaccarello, Gianluca; Carrega, Paolo; Ferlazzo, Guido; Mingari, Maria Cristina; Moretta, Lorenzo; Pistoia, Vito; Malavasi, Fabio
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase
2007-01-01 CURTI A; ALUIGI M; PANDOLFI S; FERRI E; ISIDORI A; SALVESTRINI V; DURELLI I; HORENSTEIN AL; FIORE F; MASSAIA M; PICCIOLI M; PILERI SA; ZAVATTO E; D'ADDIO A; BACCARANI M; LEMOLI RM
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.
2013-01-01 Chillemi A;Zaccarello G;Quarona V;Ferracin M;Ghimenti C;Massaia M;Horenstein AL;Malavasi F
Biosensor analysis of antigen-antibody interactions as a priority step in the generation of monoclonal bispecific antibodies.
1994-01-01 HORENSTEIN A ;POIESI C ;CAMAGNA M ;DE MONTE L ;MARIANI M ;ALBERTINI A ;MALAVASI F
CD157, the Janus of CD38 but with a unique personality.
2002-01-01 Ortolan E; Vacca P; Capobianco A; Armando E; Crivellin F; Horenstein A; Malavasi F.
CD38 and bone marrow microenvironment.
2014-01-01 Chillemi A;Zaccarello G;Quarona V;Lazzaretti M;Martella E;Giuliani N;Ferracini R;Pistoia V;Horenstein AL;Malavasi F
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival
2005-01-01 DEAGLIO S; VAISITTI T; BERGUI L; BONELLO L; HORENSTEIN AL; TAMAGNONE L; BOUMSELL L; MALAVASI F
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity
2006-01-01 MALAVASI F; DEAGLIO S; FERRERO E; FUNARO A; SANCHO J; AUSIELLO CM; ORTOLAN E; VAISITTI T; ZUBIAUR M; FEDELE G; AYDIN S; TIBALDI EV; DURELLI I; LUSSO R; CORNO F; HORENSTEIN AL
CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus
2009-01-01 Horenstein AL; Sizzano F; Lusso R; Besso FG; Ferrero E; Deaglio S; Corno F; Malavasi F
CD38 and CD157: A long journey from activation markers to multifunctional molecules.
2013-01-01 Quarona V;Zaccarello G;Chillemi A;Brunetti E;Singh VK;Ferrero E;Funaro A;Horenstein AL;Malavasi F
CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia
2005-01-01 BOLOGNESI A; POLITO L; FARINI V; BORTOLOTTI M; TAZZARI PL; RATTA M; RAVAIOLI A; HORENSTEIN AL; STIRPE F; BATTELLI MG; MALAVASI F
CD38 binding to human myeloid cells is mediated by mouse and human CD31.
1998-01-01 HORENSTEIN AL ;STOCKINGER H ;IMHOF BA ;MALAVASI F
CD38 e autismo. Genetica e ricadute nella pratica clinica
2013-01-01 Brunetti Enrico; Zaccarello Gianluca; Chillemi Antonella; Fusco Roberta; Quarona Valeria; Cometa Luisa; Gandione M; Balzola F; Omedè Paola; Geuna Massimo; Rigardetto R; Horenstein AL; Malavasi Fabio
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells
2010-01-01 Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S
CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation
2013-01-01 Fedele G;Di Girolamo M;Recine U;Palazzo R;Urbani F;Horenstein AL;Malavasi F;Ausiello CM
CD38 Workshop Report
1997-01-01 M. Morra; S. Deaglio; R. Mallone; G. Di Rosa; E. Tibaldi; G. Zini; C. Cinti; F. Saccucci; M. Reinis; A.L. Horenstein; E. Ferrero; A. Funaro; T. Katada; F. Malavasi
CD56brightCD16- NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation
2015-01-01 Morandi, Fabio; Horenstein, Alberto L.; Chillemi, Antonella; Quarona, Valeria; Chiesa, Sabrina; Imperatori, Andrea; Zanellato, Silvia; Mortara, Lorenzo; Gattorno, Marco; Pistoia, Vito; Malavasi, Fabio
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells
2011-01-01 Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes. | 2013 | Horenstein AL;Chillemi A;Zaccarello G;Bruzzone S;Quarona V;Zito A;Serra S;Malavasi F | |
| A murine, bispecific monoclonal antibody simultaneously recognizing β-Glucan and MP65 determinants in Candida species | 2016 | Zito, Andrea; Bromuro, Carla; Mandili, Giorgia; Chiani, Paola; Horenstein, Alberto L.; Malavasi, Fabio; Cauda, Roberto; Cassone, Antonio; Torosantucci, Antonella | |
| A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation | 2015 | Morandi, Fabio; Morandi, Barbara; Horenstein, Alberto L.; Chillemi, Antonella; Quarona, Valeria; Zaccarello, Gianluca; Carrega, Paolo; Ferlazzo, Guido; Mingari, Maria Cristina; Moretta, Lorenzo; Pistoia, Vito; Malavasi, Fabio | |
| Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase | 2007 | CURTI A; ALUIGI M; PANDOLFI S; FERRI E; ISIDORI A; SALVESTRINI V; DURELLI I; HORENSTEIN AL; FIORE F; MASSAIA M; PICCIOLI M; PILERI SA; ZAVATTO E; D'ADDIO A; BACCARANI M; LEMOLI RM | |
| Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. | 2013 | Chillemi A;Zaccarello G;Quarona V;Ferracin M;Ghimenti C;Massaia M;Horenstein AL;Malavasi F | |
| Biosensor analysis of antigen-antibody interactions as a priority step in the generation of monoclonal bispecific antibodies. | 1994 | HORENSTEIN A ;POIESI C ;CAMAGNA M ;DE MONTE L ;MARIANI M ;ALBERTINI A ;MALAVASI F | |
| CD157, the Janus of CD38 but with a unique personality. | 2002 | Ortolan E; Vacca P; Capobianco A; Armando E; Crivellin F; Horenstein A; Malavasi F. | |
| CD38 and bone marrow microenvironment. | 2014 | Chillemi A;Zaccarello G;Quarona V;Lazzaretti M;Martella E;Giuliani N;Ferracini R;Pistoia V;Horenstein AL;Malavasi F | |
| CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival | 2005 | DEAGLIO S; VAISITTI T; BERGUI L; BONELLO L; HORENSTEIN AL; TAMAGNONE L; BOUMSELL L; MALAVASI F | |
| CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity | 2006 | MALAVASI F; DEAGLIO S; FERRERO E; FUNARO A; SANCHO J; AUSIELLO CM; ORTOLAN E; VAISITTI T; ZUBIAUR M; FEDELE G; AYDIN S; TIBALDI EV; DURELLI I; LUSSO R; CORNO F; HORENSTEIN AL | |
| CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus | 2009 | Horenstein AL; Sizzano F; Lusso R; Besso FG; Ferrero E; Deaglio S; Corno F; Malavasi F | |
| CD38 and CD157: A long journey from activation markers to multifunctional molecules. | 2013 | Quarona V;Zaccarello G;Chillemi A;Brunetti E;Singh VK;Ferrero E;Funaro A;Horenstein AL;Malavasi F | |
| CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia | 2005 | BOLOGNESI A; POLITO L; FARINI V; BORTOLOTTI M; TAZZARI PL; RATTA M; RAVAIOLI A; HORENSTEIN AL; STIRPE F; BATTELLI MG; MALAVASI F | |
| CD38 binding to human myeloid cells is mediated by mouse and human CD31. | 1998 | HORENSTEIN AL ;STOCKINGER H ;IMHOF BA ;MALAVASI F | |
| CD38 e autismo. Genetica e ricadute nella pratica clinica | 2013 | Brunetti Enrico; Zaccarello Gianluca; Chillemi Antonella; Fusco Roberta; Quarona Valeria; Cometa Luisa; Gandione M; Balzola F; Omedè Paola; Geuna Massimo; Rigardetto R; Horenstein AL; Malavasi Fabio | |
| CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells | 2010 | Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S | |
| CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation | 2013 | Fedele G;Di Girolamo M;Recine U;Palazzo R;Urbani F;Horenstein AL;Malavasi F;Ausiello CM | |
| CD38 Workshop Report | 1997 | M. Morra; S. Deaglio; R. Mallone; G. Di Rosa; E. Tibaldi; G. Zini; C. Cinti; F. Saccucci; M. Reinis; A.L. Horenstein; E. Ferrero; A. Funaro; T. Katada; F. Malavasi | |
| CD56<sup>bright</sup>CD16<sup>-</sup> NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4<sup>+</sup> T cell proliferation | 2015 | Morandi, Fabio; Horenstein, Alberto L.; Chillemi, Antonella; Quarona, Valeria; Chiesa, Sabrina; Imperatori, Andrea; Zanellato, Silvia; Mortara, Lorenzo; Gattorno, Marco; Pistoia, Vito; Malavasi, Fabio | |
| CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells | 2011 | Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio |